P30 SINGLE COHORT RESULTS FROM MAJESTEC-2: TECLISTAMAB (TEC) IN COMBINATION WITH SUBCUTANEOUS DARATUMUMAB (DARA) AND LENALIDOMIDE (LEN) IN PATIENTS WITH MULTIPLE MYELOMA (MM)

por Searle, E., Quach, H., Wong, S., Costa, L., Hulin, C., Janowski, W., Berdeja, J., Anguille, S., Matous, J., Touzeau, C., Michallet, A., Husnik, M., Vishwamitra, D., Niu, Z., Larsen, J., Chen, L., Goldberg, J., Popat, R., Spencer, A.
Publicado 2023

P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PAT...

por Broijl, A., San-Miguel, J., Suzuki, K., Krishnan, A., van de Donk, N., Cook, G., Jakubowiak, A., Madduri, D., Afifi, S., Stevens, A., Schecter, J., Deraedt, W., Kuppens, S., Mistry, P., Pacaud, L., Boccadoro, M., Gay, F., Mina, R., Rasche, L., Moreau, P., Mateos, M., Einsele, H., Sonneveld, P.
Publicado 2023

P45 HIGH-DOSE CARFILZOMIB ACHIEVES SUPERIOR ANTI-TUMOR ACTIVITY OVER LOW-DOSE AND RECAPTURES RESPONSE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RESISTANT TO LOW-DOSE CARFILZOMIB BY C...

por Zhou, X., Besse, A., Peter, J., Steinhardt, M. J., Vogt, C., Nerreter, S., Teufel, E., Stanojkovska, E., Xiao, X., Hornburger, H., Haertle, L., Mendez Lopez, M., Munawar, U., Riedel, A., Han, S., Maurits, E., Overkleeft, H. S., Florea, B., Einsele, H., Kortüm, K. M., Driessen, C., Besse, L., Rasche, L.
Publicado 2023

The Association Between Time From Emergency Department Visit to ICU Admission and Mortality in Patients With Sepsis

por Shibata, Junichiro, Osawa, Itsuki, Fukuchi, Kiyoyasu, Goto, Tadahiro
Publicado 2023

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE

por Bladé, J.
Publicado 2023

Donor and Recipient Nerve Axon Counts in Gender-affirming Radial Forearm Phalloplasty: Informing Choice of Nerve Coaptations

por Krasnoff, Chloe, Ferrin, Peter, Peters, Blair R.
Publicado 2023

P08 TEMPORAL TRENDS IN PROGNOSIS OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA (SMM) WHO MEET CRITERIA FOR BIOMARKER-DEFINED EARLY MULTIPLE MYELOMA (SLIM CRAB POSITIVE MM)

por Ludwig, H., Kainz, S., Zojer, N., Schreder, M., Hinke, A.
Publicado 2023

P42 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISP...

por van de Donk, N., Rasche, L., Touzeau, C., Chari, A., Schinke, C., Minnema, M., Berdeja, J., Oriol, A., Rodriguez-Otero, P., Askari, E., Mateos, M., Costa, L., Caers, J., Krishnan, A., Vishwamitra, D., Ma, J., Qin, X., Gries, K.S., Kato, K., Campagna, M., Masterson, T., Hilder, B., Tolbert, J., Renaud, T., Goldberg, J., Heuck, C., Moreau, P., San-Miguel, J.
Publicado 2023

P37 MULTIPLE MYELOMA MONITORING FROM ARCHIVED SERUM PROTEIN ELECTROPHORESIS GELS BY MASS SPECTROMETRY AND DE NOVO SEQUENCING

por Noori, S., Zajec, M., Russcher, H., Tintu, A.N., Broijl, A., Jacobs, J.F.M., Luider, T.M., de Rijke, Y.B., vanDuijn, M.M.
Publicado 2023

P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY AGENT AND ONE ANTI-CD38...

por Offidani, M., Morè, S., Cavo, M., Derudas, D., Di Raimondo, F., Cuneo, A., Baldini, L., Della Pepa, R., Musso, M., Boccadoro, M., Musto, P., Belotti, A., Fioritoni, F., Di Renzo, N., Mele, A., Gamberi, B., De Paoli, L., Zambello, R., Grammatico, S., Brociner, M., Fazio, F., Petrucci, M. T.
Publicado 2023

P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT

por Annibali, O., F, Fazio, M, Di Cecca, C, Liberatore, F, Pisani, L, De Padua, V, Tomarchio, R, Poggiali, F, Fioritoni, MT, Tafuri, F, Viola, G, Montanaro, M, Passucci, S, Pulini, MT, Petrucci, L, Rigacci
Publicado 2023

P53 REAL-WORLD TREATMENT SEQUENCES AND COSTS OF 96 PATIENTS WITH MULTIPLE MYELOMA FROM DIAGNOSIS TO DEATH

por Seefat, M.R., Cucchi, D.G.J., Groen, K., Donker, M.L., van der Hem, K.G., Westerman, M., Gerrits, A.M., Beeker, A., van de Donk, N., Blommestein, H.M., Zweegman, S.
Publicado 2023

P03 COMBINING SKY92 GENE EXPRESSION PROFILING AND IGH CLONALITY TO EVALUATE GENETIC RISK IN IRISH MULTIPLE MYELOMA PATIENTS

por McAvera, R, Drozdz, I, Black, H, Cichocka, T, Szegezdi, E, Quinn, J, Murphy, P, Thornton, P, Perera, M, Clifford, R, Keane, N, Mykytiv, V, Elhassadi, E, Cummins, R, O’Dwyer, M, Glavey, S
Publicado 2023

P46 SEER-MEDICARE DATABASE: REAL-WORLD TREATMENTS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED MULTIPLE MYELOMA TREATED WITH 1–3 PRIOR LINES OF THERAPY, INCLUDING...

por Einsele, H., Dhakal, B., Potluri, R., Schecter, J., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Nair, S., He, J., Voelker, J., Cost, P., Valluri, S., Yalniz, F., Pacaud, L., Yong, K.
Publicado 2023

P41 NO EVIDENCE OF B-CELL MATURATION ANTIGEN (BCMA) EXPRESSION LOSS OR SYSTEMIC IMMUNE IMPAIRMENT AFTER TREATMENT WITH THE BCMA-TARGETED ANTIBODY-DRUG CONJUGATE BELANTAMAB MAFODOTI...

por Lowther, D.E., Houseman, E.A., Han, G., Kleanthous, E., Knoblock, D., Zhou, X., Banerjee, S., Patel, S., Figueroa, D.
Publicado 2023

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B...

por van de Donk, N., Mateos, M.-V., Cohen, Y.C., Rodriguez-Otero, P., Paiva, B., Cohen, A.D., Martin, T., Suvannasankha, A., Madduri, D., Corsale, C., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Deraedt, W., Roccia, T., Mistry, P., Xu, X., Li, K., Zudaire, E., Akram, M., Pacaud, L., Avivi, I., San-Miguel, J.
Publicado 2023

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR...

por van de Donk, N., Minnema, M.C., van der Holt, B., Schjesvold, F., Wu, K.L., Capra, A., Broyl, A., Roeloffzen, W.W.H., Gadisseur, A.P.A., Pietrantuono, G., Pour, L., van der Velden, V., Lund, T., Offidani, M., Grasso, M., Giaccone, L., Cavo, M., Silkjaer, T., Caers, J., Zweegman, S., Hajek, R., Benjamin, R., Vangsted, A., Boccadoro, M., Gay, F., Sonneveld, P., Musto, P.
Publicado 2023

P20 LENALIDOMIDE MAINTENANCE AFTER VTD INDUCTION AND AUTOLOGOUS STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A REAL-LIFE STUDY INCLUDING 389 PATIENTS

por Barilà, G., Pascarella, A., Conticello, C., Mina, R., Marcon, C., Fazio, F., Cartia, C., Buda, G., Pilerci, S., Rocchi, S., Maroccia, A., Sgherza, N., Porrazzo, M., Pescosta, N., Furlan, A., Scomazzon, E., Mele, G., Gentile, M., Del Giudice, M.L., Schininà, G., Pavan, L., De Cicco, G., Casson, A., Lisi, C., Antonioli, E., Mangiacavalli, S., Musto, P., Gay, F., Zamagni, E., Petrucci, M.T., Di Raimondo, F., Patriarca, F., Bassan, R., Zambello, R.
Publicado 2023

Novel Custom Maxillary Disimpaction Splint

por Jolly, Lisa, Sudduth, Jack D., Marquez, Jessica L., White, Michelle, Collar-Yagas, Lucia, Yamashiro, Duane, Siddiqi, Faizi, Gociman, Barbu
Publicado 2023

P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA

por Duminuco, A., Romano, A., Leotta, D., La Spina, E., Cambria, D., Bulla, A., Del Fabro, V., Tibullo, D., Giallongo, C., Palumbo, G.A., Conticello, C., Di Raimondo, F.
Publicado 2023